ArticleEuropean urology2017

Re: Multi-institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy.

Aditya Bagrodia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.